Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. develops drug delivery and consumer-product dosing, dispensing and protection technologies for pharmaceutical, beauty, food, beverage, personal care and home care markets. News about ATR commonly covers operating results across Pharma, Beauty and Closures, demand trends in prescription drug delivery, biologics, injectables, nasal delivery, fragrance dispensing and closure applications.
Company updates also include product introductions such as inverted lidless dispensing closures using SimpliSqueeze® valve technology, Aptar Pharma delivery systems used in clinical-stage nasal therapies, Aptar Digital Health partnerships, dividend declarations, share repurchases and investor presentations.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
AptarGroup, Inc. (NYSE:ATR) reported a strong third quarter for 2020, with sales increasing by 8% to $759 million, driven by currency effects and recent acquisitions. The Pharma segment saw core sales growth of 11%, while Beauty + Home and Food + Beverage segments experienced slower growth, impacted by COVID-19. Reported earnings per share rose 12% to $0.95. Year-to-date sales were stable at $2.18 billion. The company anticipates continued core sales growth in Q4, expecting EPS between $0.84 and $0.92. A quarterly dividend of $0.36 per share was declared, payable November 18, 2020.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, with a payment date set for November 18, 2020 for shareholders on record as of October 28, 2020. Additionally, the company plans to hold a conference call on October 30, 2020, at 8:00 a.m. Central Time to discuss its third-quarter results for 2020. Investors can access a live webcast on the company's Investor Relations page.